Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Robocath, which is developing robotic-assisted technology for cardiovascular diseases, has formed a strategic partnership with Microport in connection with a $43.4m round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NetScientific's pre-tax loss was halved to $6.5m during 2019, and the firm also reported improved cash availability.

Otsuka Pharmaceuticals's McQuade Center for Strategic Research and Development backed the psilocybin-based mental health drug developer through the round.

Terese Hougaard has taken a principal role at the UK-based venture firm after five years at Alphabet unit CapitalG, most recently as a partner.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

M Ventures and Novartis Venture Fund co-led a round for the oncology drug startup that also featured fellow corporate venturing unit Pfizer Ventures.

EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

Satt AxLR-allied Phost'in Therapeutics has secured funding to progress cancer drugs targeting glycosylation and the body's immune system.